marketcaparena
Search

    ICUI

    ICU MEDICAL INC/DE

    Company overview

    Market capitalization
    $4.10B
    Employees
    13,000
    Latest publication
    2026-09-29
    About ICU MEDICAL INC/DE

    ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue551,683,000USD530,374,000USD540,310,000USD536,990,000USD548,866,000USD604,702,000USD629,805,000USD589,131,000USD
    Cost Of Revenue316,630,000USD357,277,000USD338,181,000USD336,109,000USD340,802,000USD394,593,000USD402,547,000USD384,279,000USD
    Gross Profit235,053,000USD173,097,000USD202,129,000USD200,881,000USD208,064,000USD210,109,000USD227,258,000USD204,852,000USD
    Research Development22,702,000USD21,280,000USD21,086,000USD21,251,000USD21,867,000USD23,291,000USD22,355,000USD21,028,000USD
    Selling General Administrative151,922,000USD154,566,000USD155,812,000USD152,773,000USD159,392,000USD157,233,000USD158,849,000USD162,707,000USD
    Total Operating Expenses195,926,000USD142,419,000USD176,898,000USD187,162,000USD197,477,000USD197,221,000USD189,567,000USD196,616,000USD
    Operating Income39,127,000USD30,678,000USD25,231,000USD13,719,000USD10,587,000USD12,888,000USD37,691,000USD8,236,000USD
    Total Other Income Expense Net-15,983,000USD-35,260,000USD-43,618,000USD-17,773,000USD25,929,000USD-23,794,000USD-29,474,000USD-26,164,000USD
    Interest Expense15,747,000USD19,751,000USD24,836,000USD19,808,000USD23,065,000USD29,019,000USD26,188,000USD27,287,000USD
    Income Before Tax23,144,000USD-4,582,000USD-18,387,000USD-4,054,000USD36,516,000USD-10,906,000USD8,217,000USD-17,928,000USD
    Income Tax Expense7,070,000USD-34,714,000USD-2,653,000USD-658,000USD1,178,000USD4,570,000USD32,045,000USD15,055,000USD
    Equity Method Income Loss3,013,000USD———————
    Net Income19,087,000USD30,132,000USD-15,734,000USD-3,396,000USD35,338,000USD-15,476,000USD-23,828,000USD-32,983,000USD
    Unclassified Operating Expenses—-33,427,000USD—13,138,000USD16,218,000USD16,697,000USD8,363,000USD12,881,000USD
    Interest Income—2,039,000USD2,138,000USD2,421,000USD2,516,000USD3,232,000USD2,731,000USD2,604,000USD
    Net Interest Income—-16,494,000USD-20,643,000USD-19,808,000USD-20,549,000USD-22,031,000USD-23,457,000USD-24,683,000USD
    Tax Provision—-34,714,000USD-2,653,000USD-658,000USD1,178,000USD4,570,000USD32,045,000USD15,055,000USD
    Net Income From Continuing Ops—30,132,000USD-15,734,000USD-3,396,000USD35,338,000USD-15,476,000USD-23,828,000USD-32,983,000USD
    Ebit—-21,076,000USD6,449,000USD15,754,000USD56,744,000USD14,357,000USD34,405,000USD9,359,000USD
    Ebitda—28,951,000USD60,790,000USD66,556,000USD106,409,000USD63,802,000USD87,417,000USD64,959,000USD
    Depreciation And Amortization—50,027,000USD54,341,000USD50,802,000USD49,665,000USD49,445,000USD53,012,000USD55,600,000USD
    Reconciled Depreciation—50,000,000USD50,829,000USD50,802,000USD49,665,000USD49,445,000USD53,012,000USD55,600,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue2,230,025,000USD2,382,046,000USD2,259,126,000USD1,316,308,000USD1,271,004,000USD1,266,208,000USD1,400,040,000USD1,292,613,000USD
    Cost Of Revenue1,410,370,000USD1,557,264,000USD1,519,253,000USD824,818,000USD809,507,000USD794,344,000USD830,012,000USD866,518,000USD
    Gross Profit819,655,000USD824,782,000USD739,873,000USD491,490,000USD461,497,000USD471,864,000USD570,028,000USD426,095,000USD
    Research Development87,495,000USD88,615,000USD85,344,000USD47,498,000USD42,948,000USD48,611,000USD52,867,000USD51,253,000USD
    Selling General Administrative625,210,000USD638,762,000USD606,693,000USD302,583,000USD283,953,000USD276,882,000USD328,146,000USD303,953,000USD
    Total Operating Expenses712,705,000USD781,818,000USD717,048,000USD368,245,000USD363,335,000USD364,504,000USD381,013,000USD355,206,000USD
    Operating Income106,950,000USD42,964,000USD22,825,000USD123,245,000USD98,162,000USD107,360,000USD21,612,000USD-15,078,000USD
    Interest Income10,307,000USD10,788,000USD7,508,000USD2,840,000USD1,924,000USD6,251,000USD3,409,000USD247,000USD
    Interest Expense105,380,000USD106,541,000USD102,727,000USD858,000USD1,753,000USD549,000USD709,000USD2,047,000USD
    Net Interest Income-83,031,000USD-95,753,000USD-95,219,000USD-858,000USD-1,753,000USD-549,000USD-709,000USD-2,047,000USD
    Income Before Tax3,169,000USD-66,012,000USD-78,299,000USD123,186,000USD97,494,000USD114,707,000USD22,374,000USD51,283,000USD
    Income Tax Expense2,437,000USD51,676,000USD-48,644,000USD20,051,000USD10,624,000USD13,672,000USD-6,419,000USD-17,361,000USD
    Tax Provision2,437,000USD51,676,000USD-48,644,000USD20,051,000USD10,624,000USD13,672,000USD-6,419,000USD-17,361,000USD
    Net Income732,000USD-117,688,000USD-29,655,000USD103,135,000USD86,870,000USD101,035,000USD28,793,000USD68,644,000USD
    Net Income From Continuing Ops732,000USD-117,688,000USD-29,655,000USD103,135,000USD86,870,000USD101,035,000USD28,793,000USD68,644,000USD
    Ebit108,549,000USD40,529,000USD24,428,000USD124,166,000USD99,247,000USD115,256,000USD197,159,000USD138,973,000USD
    Ebitda326,541,000USD42,964,000USD253,202,000USD223,458,000USD194,094,000USD192,172,000USD271,894,000USD205,542,000USD
    Depreciation And Amortization217,992,000USD2,435,000USD228,774,000USD99,292,000USD94,847,000USD76,916,000USD74,735,000USD66,569,000USD
    Reconciled Depreciation200,741,000USD219,512,000USD228,774,000USD89,698,000USD94,847,000USD85,210,000USD74,735,000USD66,569,000USD
    Total Other Income Expense Net-103,781,000USD-108,976,000USD-101,124,000USD-59,000USD-668,000USD7,347,000USD-7,382,000USD64,577,000USD
    Unclassified Operating Expenses—54,441,000USD25,011,000USD18,164,000USD36,434,000USD38,911,000USD——
    Non Operating Income Net Other———799,000USD1,085,000USD7,896,000USD1,471,000USD68,408,000USD
    Net Income Applicable To Common Shares———103,135,000USD86,870,000USD101,035,000USD28,793,000USD68,644,000USD
    Selling And Marketing Expenses—————100,000USD600,000USD200,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets3,971,282,000USD4,013,763,000USD4,050,508,000USD4,102,896,000USD4,107,389,000USD4,184,581,000USD4,203,931,000USD4,305,038,000USD
    Cash And Equivalents298,299,000USD———————
    Total Current Assets1,210,908,000USD1,188,981,000USD1,177,444,000USD1,207,290,000USD1,180,115,000USD1,423,915,000USD1,441,983,000USD1,258,055,000USD
    Other Current Assets121,657,000USD93,984,000USD73,107,000USD67,883,000USD44,445,000USD339,210,000USD346,045,000USD54,729,000USD
    Other Non Current Assets63,435,000USD———————
    Total Liabilities1,819,431,000USD———————
    Total Current Liabilities498,364,000USD517,904,000USD498,861,000USD492,900,000USD482,777,000USD549,024,000USD556,182,000USD549,557,000USD
    Other Current Liabilities322,489,000USD———————
    Other Non Current Liabilities70,994,000USD———————
    Total Equity Including Noncontrolling Interest2,151,851,000USD———————
    Short Long Term Debt18,750,000USD18,750,000USD18,750,000USD——47,813,000USD51,000,000USD51,000,000USD
    Long Term Debt1,212,449,000USD1,261,826,000USD1,265,917,000USD1,313,931,000USD1,337,731,000USD1,488,565,000USD1,531,858,000USD1,543,342,000USD
    Net Receivables183,531,000USD201,077,000USD180,515,000USD217,232,000USD219,171,000USD204,675,000USD202,696,000USD198,776,000USD
    Inventory607,421,000USD605,590,000USD615,859,000USD622,443,000USD616,474,000USD590,326,000USD584,676,000USD692,038,000USD
    Property Plant Equipment Net485,408,000USD502,135,000USD506,287,000USD512,565,000USD511,330,000USD503,329,000USD499,300,000USD658,528,000USD
    Goodwill1,484,384,000USD———————
    Intangible Assets567,665,000USD598,968,000USD633,559,000USD664,827,000USD698,009,000USD716,667,000USD740,789,000USD785,823,000USD
    Accounts Payable149,165,000USD173,982,000USD154,374,000USD171,752,000USD168,820,000USD180,409,000USD148,020,000USD168,562,000USD
    Common Stock2,519,000USD2,519,000USD2,469,000USD2,469,000USD2,469,000USD2,461,000USD2,452,000USD2,446,000USD
    Retained Earnings740,109,000USD721,022,000USD690,890,000USD706,624,000USD710,020,000USD674,682,000USD690,158,000USD713,986,000USD
    Accumulated Other Comprehensive Income-43,336,000USD-51,897,000USD-34,629,999USD-32,977,000USD-32,642,000USD-105,395,000USD-139,401,000USD-62,436,000USD
    Total Liab—1,901,835,000USD1,926,683,000USD1,975,646,000USD1,991,613,000USD2,196,892,000USD2,238,696,000USD2,256,451,000USD
    Total Stockholder Equity—2,111,928,000USD2,123,824,999USD2,127,250,000USD2,115,776,000USD1,987,689,000USD1,965,235,000USD2,048,587,000USD
    Other Current Liab—238,479,000USD265,573,999USD287,203,000USD291,879,000USD255,398,000USD299,865,000USD271,425,000USD
    Capital Stock—2,519,000USD2,469,000USD2,469,000USD2,469,000USD2,461,000USD2,452,000USD2,446,000USD
    Good Will—1,485,561,000USD1,499,754,000USD1,498,767,000USD1,501,920,000USD1,455,113,000USD1,432,772,000USD1,478,293,000USD
    Cash—288,330,000USD307,963,000USD299,732,000USD300,025,000USD289,704,000USD308,566,000USD312,512,000USD
    Cash And Short Term Investments—288,330,000USD307,963,000USD299,732,000USD300,025,000USD289,704,000USD308,566,000USD312,512,000USD
    Current Deferred Revenue—60,656,000USD33,843,000USD28,900,000USD21,919,000USD32,485,000USD30,358,000USD26,932,000USD
    Net Debt—1,052,907,000USD1,084,255,000USD1,064,810,000USD1,090,190,000USD1,310,722,000USD1,333,096,000USD1,346,492,000USD
    Short Term Debt—34,185,000USD34,670,000USD15,576,000USD29,472,000USD61,285,000USD66,695,000USD68,094,000USD
    Short Long Term Debt Total—1,341,237,000USD1,392,218,000USD1,364,542,000USD1,390,215,000USD1,600,426,000USD1,641,662,000USD1,659,004,000USD
    Long Term Investments—130,918,000USD131,586,000USD134,086,000USD131,625,000USD3,038,000USD3,038,000USD3,080,000USD
    Property Plant Equipment Gross—1,156,651,000USD1,157,799,000USD1,148,187,000USD1,141,660,000USD1,111,236,000USD1,092,197,000USD1,343,544,000USD
    Common Stock Shares Outstanding—25,182,000shares24,687,000shares24,686,000shares24,708,000shares24,539,000shares24,492,000shares24,438,000shares
    Non Current Assets Total—2,824,782,000USD2,859,954,000USD2,895,606,000USD2,927,274,000USD2,760,666,000USD2,761,948,000USD3,046,983,000USD
    Non Current Liabilities Total—1,383,931,000USD1,427,822,000USD1,482,746,000USD1,508,836,000USD1,647,868,000USD1,682,514,000USD1,706,894,000USD
    Non Current Liabilities Other—37,107,000USD41,856,000USD42,947,000USD43,805,000USD13,965,000USD10,143,000USD18,177,000USD
    Non Currrent Assets Other—80,793,000USD62,877,000USD61,385,000USD61,322,000USD58,272,000USD61,838,000USD80,613,000USD
    Net Working Capital—695,341,000USD691,693,000USD714,390,000USD697,338,000USD874,891,000USD885,801,000USD708,498,000USD
    Unclassified Current Liabilities—-8,148,000USD-8,349,999USD-10,531,000USD-29,313,000USD-28,366,000USD-39,756,000USD-36,456,000USD
    Unclassified Non Current Liabilities—84,998,000USD120,049,000USD125,868,000USD127,300,000USD145,338,000USD140,513,000USD145,375,000USD
    Unclassified Equity—1,437,765,000USD1,462,626,998USD1,448,665,000USD1,433,460,000USD1,413,480,000USD1,409,574,000USD1,392,145,000USD
    Short Term Investments——————0USD1,387,000USD
    Unclassified Non Current Assets———————40,646,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets4,050,508,000USD4,203,931,000USD4,378,439,000USD4,515,641,000USD1,880,738,000USD1,763,691,000USD1,692,382,000USD1,585,391,000USD
    Intangible Assets633,559,000USD740,789,000USD870,588,000USD982,766,000USD188,311,000USD197,231,000USD211,408,000USD133,421,000USD
    Other Current Assets73,107,000USD346,045,000USD75,042,000USD79,279,000USD47,514,000USD60,894,000USD49,701,000USD40,185,000USD
    Total Liab1,926,683,000USD2,238,696,000USD2,255,029,000USD2,425,713,000USD264,707,000USD261,426,000USD315,138,000USD321,736,000USD
    Total Stockholder Equity2,123,824,999USD1,965,235,000USD2,123,410,000USD2,089,928,000USD1,616,031,000USD1,502,265,000USD1,377,244,000USD1,263,655,000USD
    Other Current Liab265,573,999USD299,865,000USD211,521,000USD182,124,000USD90,223,000USD106,315,000USD103,718,000USD118,852,000USD
    Common Stock2,469,000USD2,452,000USD2,414,000USD2,399,000USD2,128,000USD2,106,000USD2,074,000USD2,049,000USD
    Capital Stock2,469,000USD2,452,000USD2,414,000USD2,399,000USD2,128,000USD2,106,000USD2,074,000USD2,049,000USD
    Retained Earnings690,890,000USD690,158,000USD807,846,000USD837,501,000USD911,787,000USD808,652,000USD721,782,000USD620,747,000USD
    Good Will1,499,754,000USD1,432,772,000USD1,472,446,000USD1,449,258,000USD43,439,000USD33,000,999USD31,245,000USD11,195,000USD
    Cash307,963,000USD308,566,000USD254,222,000USD208,784,000USD552,827,000USD396,097,000USD268,670,000USD344,781,000USD
    Cash And Short Term Investments307,963,000USD308,566,000USD254,723,000USD213,008,000USD567,247,000USD410,784,000USD292,637,000USD382,110,000USD
    Total Current Assets1,177,444,000USD1,441,983,000USD1,221,272,000USD1,235,196,000USD1,029,809,000USD914,375,000USD882,197,000USD927,036,000USD
    Total Current Liabilities498,861,000USD556,182,000USD481,838,000USD494,559,000USD200,777,000USD195,488,000USD248,468,000USD249,289,000USD
    Current Deferred Revenue33,843,000USD30,358,000USD31,640,000USD30,838,000USD12,646,000USD5,566,000USD6,696,000USD3,814,000USD
    Net Debt1,084,255,000USD1,333,096,000USD1,449,635,000USD1,525,519,000USD-507,780,000USD-343,396,000USD-232,412,000USD-344,781,000USD
    Short Term Debt34,670,000USD66,695,000USD71,161,000USD47,857,000USD9,009,000USD9,294,000USD7,362,000USD6,154,000USD
    Short Long Term Debt18,750,000USD51,000,000USD51,000,000USD29,688,000USD————
    Short Long Term Debt Total1,392,218,000USD1,641,662,000USD1,703,857,000USD1,734,303,000USD45,047,000USD52,701,000USD36,258,000USD—
    Long Term Debt1,265,917,000USD1,531,858,000USD1,577,770,000USD1,623,675,000USD————
    Long Term Investments131,586,000USD3,038,000USD3,120,000USD3,694,000USD4,620,000USD12,974,000USD0USD2,025,000USD
    Net Receivables180,515,000USD202,696,000USD182,147,000USD246,900,000USD124,813,000USD127,769,000USD202,219,000USD196,435,000USD
    Inventory615,859,000USD584,676,000USD709,360,000USD696,009,000USD290,235,000USD314,928,000USD337,640,000USD311,163,000USD
    Accounts Payable154,374,000USD148,020,000USD150,030,000USD215,902,000USD81,128,000USD71,864,000USD128,629,000USD120,469,000USD
    Property Plant Equipment Net506,287,000USD499,300,000USD685,525,000USD713,575,000USD510,885,000USD513,198,999USD490,550,000USD432,641,000USD
    Property Plant Equipment Gross1,157,799,000USD1,092,197,000USD1,309,413,000USD710,977,000USD468,365,000USD513,199,000USD490,550,000USD432,641,000USD
    Accumulated Other Comprehensive Income-34,629,999USD-139,401,000USD-53,081,000USD-80,978,000USD-19,269,000USD-1,522,000USD-15,402,000USD-16,945,000USD
    Common Stock Shares Outstanding24,904,000shares24,388,000shares24,091,000shares23,868,000shares21,781,000shares21,591,000shares21,545,000shares21,601,000shares
    Non Current Assets Total2,859,954,000USD2,761,948,000USD3,157,167,000USD3,280,445,000USD850,929,000USD849,316,000USD810,185,000USD658,355,000USD
    Non Current Liabilities Total1,427,822,000USD1,682,514,000USD1,773,191,000USD1,931,154,000USD63,930,000USD65,937,999USD66,670,000USD72,447,000USD
    Non Current Liabilities Other41,856,000USD10,143,000USD33,929,000USD54,355,000USD62,440,000USD64,275,000USD47,279,000USD50,763,000USD
    Non Currrent Assets Other62,877,000USD56,114,000USD88,193,000USD99,686,000USD57,832,000USD61,877,000USD48,984,000USD40,419,000USD
    Net Working Capital691,693,000USD885,801,000USD739,434,000USD740,637,000USD829,032,000USD725,289,000USD633,729,000USD677,747,000USD
    Unclassified Current Liabilities-8,349,999USD-39,756,000USD-33,514,000USD-11,850,000USD7,771,000USD2,449,000USD——
    Unclassified Non Current Liabilities120,049,000USD140,513,000USD161,492,000USD—-22,100,000USD-18,103,001USD-20,474,000USD-51,484,000USD
    Unclassified Equity1,462,626,998USD1,409,574,000USD1,363,817,000USD1,328,607,000USD719,284,000USD690,962,000USD666,873,000USD655,850,000USD
    Short Term Investments—1,207,000USD501,000USD4,224,000USD14,420,000USD14,687,000USD23,967,000USD37,329,000USD
    Unclassified Non Current Assets—29,935,000USD37,295,000USD-72,933,000USD-60,505,000USD-115,019,998USD-48,984,000USD-40,419,000USD
    Deferred Long Term Liab———5,156,000USD1,490,000USD1,663,000USD2,091,000USD721,000USD
    Other Liab———244,708,000USD22,100,000USD18,103,000USD37,774,000USD72,447,000USD
    Other Assets———104,399,000USD106,347,000USD146,054,000USD76,982,000USD79,073,000USD
    Net Tangible Assets———-342,096,000USD1,616,031,000USD1,272,033,000USD1,151,891,000USD1,119,039,000USD
    Treasury Stock————-27,000USD-39,000USD-157,000USD-95,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income30,132,000USD-15,734,000USD-3,396,000USD35,338,000USD-15,476,000USD-23,828,000USD-32,983,000USD-21,406,000USD
    Depreciation50,027,000USD54,341,000USD50,802,000USD49,665,000USD49,445,000USD52,993,000USD55,675,000USD55,318,000USD
    Stock Based Compensation14,011,000USD13,879,000USD15,243,000USD14,457,000USD12,179,000USD12,517,000USD11,770,000USD10,998,000USD
    Other Non Cash Items8,679,000USD28,836,000USD16,271,000USD-39,165,000USD17,085,000USD16,180,000USD15,121,000USD12,556,000USD
    Change To Account Receivables-24,145,000USD4,933,000USD-12,748,000USD-5,748,000USD22,439,000USD-35,327,000USD-18,232,000USD-7,252,000USD
    Change To Inventory6,088,000USD9,961,000USD-7,000,000USD-20,989,000USD-8,224,000USD7,413,000USD-11,679,000USD6,931,000USD
    Change In Working Capital-63,940,000USD-6,844,000USD-22,210,000USD-49,084,000USD-11,906,000USD-17,670,000USD-13,486,000USD24,487,000USD
    Total Cash From Operating Activities38,909,000USD60,599,000USD56,710,000USD11,211,000USD51,327,000USD40,192,000USD36,097,000USD81,953,000USD
    Capital Expenditures-11,302,000USD-24,646,000USD-29,080,000USD-22,005,000USD-14,621,000USD-26,597,000USD-14,546,000USD-19,467,000USD
    Free Cash Flow27,607,000USD35,953,000USD27,630,000USD-10,794,000USD36,706,000USD13,595,000USD21,551,000USD62,486,000USD
    Total Cashflows From Investing Activities-11,209,000USD-18,391,000USD-30,028,000USD187,459,000USD-16,811,000USD-26,546,000USD-22,860,000USD-21,692,000USD
    Net Borrowings-5,346,000USD-30,192,000USD-25,658,000USD-200,557,000USD-48,078,000USD-13,122,000USD-10,407,000USD—
    Total Cash From Financing Activities-44,122,000USD-34,485,000USD-25,689,000USD-195,015,000USD-56,336,000USD-8,191,000USD-10,380,000USD-10,384,000USD
    Change In Cash-19,633,000USD8,231,000USD-293,000USD10,321,000USD-18,862,000USD-3,946,000USD9,864,000USD51,225,000USD
    Begin Period Cash Flow307,963,000USD299,732,000USD300,025,000USD289,704,000USD308,566,000USD312,512,000USD302,648,000USD251,423,000USD
    End Period Cash Flow288,330,000USD307,963,000USD299,732,000USD300,025,000USD289,704,000USD308,566,000USD312,512,000USD302,648,000USD
    Other Cashflows From Investing Activities93,000USD-211,185,000USD-948,000USD207,155,000USD-2,190,000USD-2,465,000USD-7,622,000USD185,000USD
    Other Cashflows From Financing Activities-38,776,000USD8,719,000USD-25,689,000USD-297,000USD-8,391,000USD11,867,000USD-2,782,000USD-285,000USD
    Investments—0USD-30,028,000USD187,459,000USD-16,811,000USD-26,546,000USD-22,860,000USD-21,692,000USD
    Sale Purchase Of Stock—-8,766,000USD-31,000USD——-11,992,000USD11,685,000USD-285,000USD
    Unclassified Operating Cash Flow—-13,879,000USD——————
    Unclassified Investing Cash Flow—217,440,000USD30,028,000USD-185,150,000USD16,811,000USD29,062,000USD22,168,000USD19,282,000USD
    Unclassified Financing Cash Flow—-4,246,000USD25,689,000USD5,839,000USD—5,056,000USD-8,876,000USD-9,814,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income732,000USD-117,688,000USD-29,655,000USD-74,286,000USD103,135,000USD86,870,000USD101,035,000USD28,793,000USD
    Depreciation200,741,000USD240,856,000USD228,791,000USD235,151,000USD89,698,000USD94,847,000USD85,210,000USD74,735,000USD
    Stock Based Compensation55,758,000USD46,883,000USD40,563,000USD36,025,000USD27,341,000USD23,954,000USD21,918,000USD24,241,000USD
    Other Non Cash Items12,660,000USD36,551,000USD62,105,000USD44,710,000USD32,325,000USD30,275,000USD-22,229,000USD37,582,000USD
    Change To Account Receivables8,876,000USD-46,844,000USD48,635,000USD-19,151,000USD13,755,000USD78,049,000USD-23,684,000USD-76,742,000USD
    Change To Inventory-26,252,000USD16,829,000USD-6,079,000USD-201,095,000USD20,815,000USD19,196,000USD-24,997,000USD-21,770,000USD
    Change In Working Capital-90,044,000USD-2,569,000USD-135,603,000USD-303,729,000USD15,039,000USD-16,966,000USD-111,636,000USD-25,406,000USD
    Total Cash From Operating Activities179,847,000USD204,033,000USD166,201,000USD-62,129,000USD267,538,000USD222,752,000USD101,918,000USD160,215,000USD
    Capital Expenditures-88,043,000USD-79,373,000USD-93,670,000USD-99,329,000USD-81,169,000USD-100,390,000USD-106,040,000USD-100,779,000USD
    Free Cash Flow91,804,000USD124,660,000USD72,531,000USD-161,458,000USD186,369,000USD122,362,000USD-4,122,000USD59,436,000USD
    Investments0USD-88,960,000USD-87,947,000USD-1,909,468,000USD4,716,000USD-3,925,000USD15,252,000USD-15,056,000USD
    Total Cashflows From Investing Activities122,229,000USD-88,960,000USD-87,947,000USD-1,909,468,000USD-90,687,000USD-98,139,000USD-166,888,000USD-103,370,000USD
    Net Borrowings-304,485,000USD-52,147,000USD-30,651,000USD1,641,307,000USD-607,000USD-357,000USD-357,000USD-357,000USD
    Total Cash From Financing Activities-311,525,000USD-55,800,000USD-35,979,000USD1,637,032,000USD-16,870,000USD-40,000USD-10,907,000USD8,023,000USD
    Sale Purchase Of Stock-8,766,000USD-11,992,000USD-9,350,000USD-10,883,000USD-8,335,000USD-12,876,000USD-18,639,000USD-6,252,000USD
    Change In Cash-603,000USD54,344,000USD45,438,000USD-344,043,000USD156,730,000USD127,427,000USD-76,111,000USD54,709,000USD
    Begin Period Cash Flow308,566,000USD254,222,000USD208,784,000USD552,827,000USD396,097,000USD268,670,000USD344,781,000USD290,072,000USD
    End Period Cash Flow307,963,000USD308,566,000USD254,222,000USD208,784,000USD552,827,000USD396,097,000USD268,670,000USD344,781,000USD
    Other Cashflows From Investing Activities210,272,000USD-10,087,000USD-8,276,000USD-8,029,000USD-12,409,000USD14,561,000USD33,000USD13,765,000USD
    Other Cashflows From Financing Activities-311,525,000USD-2,600,000USD-87,947,000USD-13,060,000USD-25,635,000USD317,000USD7,732,000USD14,275,000USD
    Unclassified Financing Cash Flow313,251,000USD10,939,000USD101,319,000USD30,551,000USD18,744,000USD13,193,000USD——
    Unclassified Investing Cash Flow—89,460,000USD101,946,000USD107,358,000USD-1,825,000USD-8,385,000USD-76,133,000USD-1,300,000USD
    Dividends Paid——-9,350,000USD-10,883,000USD-1,037,000USD-317,000USD——
    Change To Liabilities———37,472,000USD9,480,000USD-93,831,000USD-41,706,000USD-26,280,000USD
    Exchange Rate Changes————-3,251,000USD2,854,000USD-234,000USD-10,159,000USD
    Cash And Cash Equivalents Changes————156,730,000USD127,427,000USD-76,111,000USD54,709,000USD
    Unclassified Operating Cash Flow—————3,772,000USD27,620,000USD20,270,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyAsia Pacific55,632,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyEMEA95,069,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyOtherforeigncountries51,081,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States349,901,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductInfusion Consumables289,276,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductInfusion Systems188,998,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductVital Care73,409,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific58,299,000USD0000883984-26-000029
    Q1 2026Quarterly · 2026-03-31GeographyEMEA104,676,000USD0000883984-26-000029
    Q1 2026Quarterly · 2026-03-31GeographyOtherforeigncountries51,747,000USD0000883984-26-000029
    Q1 2026Quarterly · 2026-03-31GeographyUnited States315,503,000USD0000883984-26-000029
    Q1 2026Quarterly · 2026-03-31ProductInfusion Consumables278,275,000USD0000883984-26-000029
    Q1 2026Quarterly · 2026-03-31ProductInfusion Systems179,604,000USD0000883984-26-000029
    Q1 2026Quarterly · 2026-03-31ProductVital Care72,346,000USD0000883984-26-000029
    Q4 2025Quarterly · 2025-12-31ProductInfusion Consumables284,682,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductInfusion Systems176,303,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductVital Care79,719,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAPACDomain232,903,000USD0000883984-26-000008
    FY 2025Yearly · 2025-12-31GeographyEMEA411,684,000USD0000883984-26-000008
    FY 2025Yearly · 2025-12-31GeographyOtherforeigncountries230,561,000USD0000883984-26-000008
    FY 2025Yearly · 2025-12-31GeographyUnited States1,356,114,000USD0000883984-26-000008
    FY 2025Yearly · 2025-12-31ProductInfusion Consumables1,109,130,000USD0000883984-26-000008
    FY 2025Yearly · 2025-12-31ProductInfusion Systems684,208,000USD0000883984-26-000008
    FY 2025Yearly · 2025-12-31ProductVital Care437,924,000USD0000883984-26-000008
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific57,477,000USD0000883984-25-000035
    Q3 2025Quarterly · 2025-09-30GeographyEMEA115,092,000USD0000883984-25-000035
    Q3 2025Quarterly · 2025-09-30GeographyOtherforeigncountries57,290,000USD0000883984-25-000035
    Q3 2025Quarterly · 2025-09-30GeographyUnited States307,131,000USD0000883984-25-000035
    Q3 2025Quarterly · 2025-09-30ProductInfusion Consumables285,089,000USD0000883984-25-000035
    Q3 2025Quarterly · 2025-09-30ProductInfusion Systems173,909,000USD0000883984-25-000035
    Q3 2025Quarterly · 2025-09-30ProductVital Care77,992,000USD0000883984-25-000035
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific58,404,000USD0000883984-25-000030
    Q2 2025Quarterly · 2025-06-30GeographyEMEA99,059,000USD0000883984-25-000030
    Q2 2025Quarterly · 2025-06-30GeographyOtherforeigncountries55,971,000USD0000883984-25-000030
    Q2 2025Quarterly · 2025-06-30GeographyUnited States335,432,000USD0000883984-25-000030
    Q2 2025Quarterly · 2025-06-30ProductInfusion Consumables273,133,000USD0000883984-25-000030
    Q2 2025Quarterly · 2025-06-30ProductInfusion Systems167,696,000USD0000883984-25-000030
    Q2 2025Quarterly · 2025-06-30ProductVital Care108,037,000USD0000883984-25-000030
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific59,411,000USD0000883984-26-000029
    Q1 2025Quarterly · 2025-03-31GeographyEMEA95,688,000USD0000883984-26-000029
    Q1 2025Quarterly · 2025-03-31GeographyOtherforeigncountries61,358,000USD0000883984-26-000029
    Q1 2025Quarterly · 2025-03-31GeographyUnited States388,245,000USD0000883984-26-000029
    Q1 2025Quarterly · 2025-03-31ProductInfusion Consumables266,226,000USD0000883984-26-000029
    Q1 2025Quarterly · 2025-03-31ProductInfusion Systems166,300,000USD0000883984-26-000029
    Q1 2025Quarterly · 2025-03-31ProductVital Care172,176,000USD0000883984-26-000029
    Q4 2024Quarterly · 2024-12-31ProductInfusion Consumables268,139,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductInfusion Systems171,665,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductVital Care190,001,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAPACDomain232,820,000USD0000883984-26-000008
    FY 2024Yearly · 2024-12-31GeographyEMEA393,530,000USD0000883984-26-000008
    FY 2024Yearly · 2024-12-31GeographyOtherforeigncountries223,592,000USD0000883984-26-000008
    FY 2024Yearly · 2024-12-31GeographyUnited States1,532,104,000USD0000883984-26-000008
    FY 2024Yearly · 2024-12-31ProductInfusion Consumables1,038,869,000USD0000883984-26-000008
    FY 2024Yearly · 2024-12-31ProductInfusion Systems652,410,000USD0000883984-26-000008
    FY 2024Yearly · 2024-12-31ProductVital Care690,767,000USD0000883984-26-000008
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific60,288,000USD0000883984-25-000035
    Q3 2024Quarterly · 2024-09-30GeographyEMEA101,710,000USD0000883984-25-000035
    Q3 2024Quarterly · 2024-09-30GeographyOtherforeigncountries57,618,000USD0000883984-25-000035
    Q3 2024Quarterly · 2024-09-30GeographyUnited States369,515,000USD0000883984-25-000035
    Q3 2024Quarterly · 2024-09-30ProductInfusion Consumables264,875,000USD0000883984-25-000035
    Q3 2024Quarterly · 2024-09-30ProductInfusion Systems159,769,000USD0000883984-25-000035
    Q3 2024Quarterly · 2024-09-30ProductVital Care164,487,000USD0000883984-25-000035
    Q2 2024Quarterly · 2024-06-30GeographyAsia Pacific61,224,000USD0000883984-25-000030
    Q2 2024Quarterly · 2024-06-30GeographyEMEA95,310,000USD0000883984-25-000030
    Q2 2024Quarterly · 2024-06-30GeographyOtherforeigncountries56,781,000USD0000883984-25-000030
    Q2 2024Quarterly · 2024-06-30GeographyUnited States383,140,000USD0000883984-25-000030
    Q1 2024Quarterly · 2024-03-31GeographyAsia Pacific51,853,000USD0000883984-25-000016
    Q1 2024Quarterly · 2024-03-31GeographyEMEA98,389,000USD0000883984-25-000016
    Q1 2024Quarterly · 2024-03-31GeographyOtherforeigncountries50,258,000USD0000883984-25-000016
    Q1 2024Quarterly · 2024-03-31GeographyUnited States366,155,000USD0000883984-25-000016
    FY 2023Yearly · 2023-12-31GeographyAPACDomain241,699,000USD0000883984-26-000008
    FY 2023Yearly · 2023-12-31GeographyEMEA373,571,000USD0000883984-26-000008
    FY 2023Yearly · 2023-12-31GeographyOtherforeigncountries203,839,000USD0000883984-26-000008
    FY 2023Yearly · 2023-12-31GeographyUnited States1,440,017,000USD0000883984-26-000008
    FY 2023Yearly · 2023-12-31ProductInfusion Consumables969,129,000USD0000883984-26-000008
    FY 2023Yearly · 2023-12-31ProductInfusion Systems629,043,000USD0000883984-26-000008
    FY 2023Yearly · 2023-12-31ProductVital Care660,954,000USD0000883984-26-000008
    FY 2022Yearly · 2022-12-31GeographyAPACDomain257,208,000USD0000883984-25-000007
    FY 2022Yearly · 2022-12-31GeographyEMEA367,411,000USD0000883984-25-000007
    FY 2022Yearly · 2022-12-31GeographyOtherforeigncountries195,309,000USD0000883984-25-000007
    FY 2022Yearly · 2022-12-31GeographyUnited States1,460,069,000USD0000883984-25-000007
    FY 2022Yearly · 2022-12-31ProductCritical Care47,330,000USD0000883984-23-000009
    FY 2022Yearly · 2022-12-31ProductInfusion Consumables566,617,000USD0000883984-23-000009
    FY 2022Yearly · 2022-12-31ProductInfusion Consumables Smiths Medical340,124,000USD0000883984-23-000009
    FY 2022Yearly · 2022-12-31ProductInfusion Systems351,080,000USD0000883984-23-000009
    FY 2022Yearly · 2022-12-31ProductIVSolutions363,472,000USD0000883984-23-000009
    FY 2022Yearly · 2022-12-31ProductVascular Access326,765,000USD0000883984-23-000009
    FY 2022Yearly · 2022-12-31ProductVital Care284,609,000USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31GeographyAPACDomain85,692,000USD0000883984-24-000005
    FY 2021Yearly · 2021-12-31GeographyEMEA147,488,000USD0000883984-24-000005
    FY 2021Yearly · 2021-12-31GeographyOtherforeigncountries141,319,000USD0000883984-24-000005
    FY 2021Yearly · 2021-12-31GeographyUnited States941,809,000USD0000883984-24-000005
    FY 2021Yearly · 2021-12-31ProductCritical Care49,321,000USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31ProductInfusion Consumables555,189,000USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31ProductInfusion Consumables Smiths Medical0USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31ProductInfusion Systems352,321,000USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31ProductIVSolutions359,477,000USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31ProductVascular Access0USD0000883984-23-000009
    FY 2021Yearly · 2021-12-31ProductVital Care0USD0000883984-23-000009
    FY 2020Yearly · 2020-12-31GeographyAPACDomain79,610,000USD0000883984-23-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.